CLYYF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Celyad Oncology SA (CLYYF) Ownership - Who owns Celyad Oncology SA?

Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of innovative technologies for chimeric antigen receptor T-cell (CAR T) therapies... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Rue Edouard Belin 2

Phone

+32 10394100

Employees

Web

https://www.celyad.com

Details

Group

Domestic Stock Funds

Fundamentals

CLYYF

Capitalization

21.3M

P/E Ratio

N/A

Risk (Beta)

0.05

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.00%

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

24.10

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

20.3K

Shares Outstanding - Current

41.4M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

-1

Gain YTD

165.306

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology